ID   MKN45/F2R
AC   CVCL_QY39
DR   cancercelllines; CVCL_QY39
DR   Wikidata; Q54905825
RX   PubMed=19020740;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI:46345; 5-fluorouracil (5-FU).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg110Cys (c.328C>T); ClinVar=VCV000142206; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0434 ! MKN45
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 05-10-23; Version: 9
//
RX   PubMed=19020740; DOI=10.3892/or_00000178;
RA   Tsutani Y., Yoshida K., Sanada Y., Wada Y., Konishi K., Fukushima M.,
RA   Okada M.;
RT   "Decreased orotate phosphoribosyltransferase activity produces
RT   5-fluorouracil resistance in a human gastric cancer cell line.";
RL   Oncol. Rep. 20:1545-1551(2008).
//